Characteristic Group A: with ICI (n=65) Group B: without ICI (n=62)
Age(years), median(range) 60 (46-78) 58(41-81)
Gender, n(%)
Male 46 (70.8) 41 (66.1)
Female 19 (29.2) 21 (33.9)
Tumor location, n(%)
Right colon 24 (36.9) 19 (30.6)
Left colon 41 (63.1) 43 (69.4)
MMR, n(%)
dMMR 9 (13.8) 0
pMMR 56 (86.2) 62 (100)
KRAS, n(%)
KRAS mutant 37 (56.9) 26 (41.9)
KRAS wild 28 (43.1) 36 (58.1)
Combined with targeted therapy, n(%)
Yes 24 (36.9) 62 (100)
No 41 (63.1) 0
Liver metastases, n(%)
Yes 51 (78.5) 45 (72.6)
No 14 (21.5) 17 (27.4)
Lymph nodes metastases, n(%)
Yes 48 (73.8) 41 (66.1)
No 17 (26.2) 21 (33.9)